This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Phase II trial of Linsitinib (anti-IGFR/IR) in pat...
Clinical trial

Phase II trial of Linsitinib (anti-IGFR/IR) in patients with relapsed and/or refractory Ewing Sarcoma

Read time: 1 mins
Last updated:8th Mar 2013
To determine the effect of the trial drug (linsitinib) on the patient�s tumours in terms of changes in biomarker and PET scans. To establish the safety of the trial drug (linsitinib) in Ewing sarcoma at the dose and treatment schedule being used in the trial.
Category Value
Study start date 2013-03-08

View full details